Article: Durect, Voyager Collaborate To Develop Alzheimer's Treatment.

Article from:
BIOWORLD Today
Article date:
November 4, 2009
Copyright

Staff Writer

Durect Corp. and Voyager Pharmaceutical Corp. entered a development and commercialization agreement on a product using Voyager's patented product for Alzheimer's disease.

Durect, of Cupertino, Calif., will use its Durin drug delivery technology to provide a sustained-release therapy.

"It's our theory and hypothesis that Alzheimer's disease is caused by erroneous cell division in the brain, and we believe we've shown in the lab that by stopping this cell division, it stops the disease," Voyager CEO Patrick Smith told BioWorld Today.

The agreement gives Raleigh, N.C.-based Voyager the rights to commercialize the product ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: DURECT, VOYAGER COLLABORATE TO DEVELOP ALZHEIMER'S ...
BIOWORLD Today;  July 30, 2002 ;     700+ words ...Durect Corp. and Voyager Pharmaceutical Corp ... product worldwide. Durect will receive from Voyager undisclosed milestone ... chose Durect, said Durect Chief Scientific Officer Felix Theeuwes. "Voyager is a very experienced ...

Article: Durect, Voyager win IND for use of Durin implant ...
Medical Device Daily;  December 27, 2004 ;     700+ words ...Durect, Voyager win IND for use of ... pleasure to work with Voyager to bring this product ... clinical development. Durect reports that has been ... owned subsidiary of Durect, provides knowledge ... president and CEO of Voyager, said, The launch ...

Article: DURECT and Voyager Pharmaceutical Announce the ...
PR Newswire;  December 20, 2004 ;     700+ words ...DURECT Corporation , an emerging ... systems company, and Voyager Pharmaceutical Corporation ... available at http://www.durect.com/. About Voyager Pharmaceutical Corporation ... press release regarding DURECT's and Voyager Pharmaceutica

Article: DURECT Provides an Update to the Memryte(TM) Program Under ...
PR Newswire;  October 19, 2006 ;     700+ words ...CUPERTINO, Calif., Oct. 19 /PRNewswire-FirstCall/ -- DURECT Corporation announced today that Voyager Pharmaceutical has informed DURECT that Voyager is ending its Phase III clinical trials for Memryte(TM) for the treatment ...

Article: DURECT Amends Agreement with Voyager Governing ...
PR Newswire;  January 24, 2007 ;     700+ words ... ... company. In return, DURECT will pay Voyager $1 million in cash ... In July 2002, DURECT entered into a feasibility ... commercialization agreement with Voyager under which we granted ... is a trademark of DURECT Corporation, and ... is a trademark of Voyager Pharmaceutical Corporation ...

Article: Voyager-Durect Alzheimer therapy enters Phase ...
Pharma Marketletter;  February 14, 2005 ;     609 words ...Voyager Pharmaceutical Corp of ... delivery technology firm Durect have announced completion ... disease. In July 2002, Durect entered into an agreement with Voyager Pharmaceutical providing ... the product worldwide. Durect will receive payments ...

Article: DURECT Corporation Announces Initiation of Dosing for ...
PR Newswire;  October 14, 2005 ;     700+ words ... ... PRNewswire-FirstCall/ -- DURECT Corporation , an emerging ... program under development with Voyager Pharmaceuticals for the treatment ... DVM, President and CEO of DURECT. "It has been a pleasure to work with Voyager on this important program ...

Article: Durect begins Ph III trial of Memryte AD ...
Pharma Marketletter;  October 24, 2005 ;     696 words ...Specialty drugmaker Durect, headquartered in California ... developing with fellow US firm Voyager Pharmaceuticals. The trial ... mild-to-moderate AD. Durect president James Brown said ... our pleasure to work with Voyager on this very important program ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives